e.g. Tata motors, Reliance MF, 500570

Bafna Pharmaceuticals Ltd. - Research Center

532989 BAFNAPH Group (T) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 26 Mar ' 25 Mar ' 24 Mar ' 23 Mar ' 22
Income
Operating income 150.62 145.86 152.47 115.35 85.14
Expenses
Material consumed 83.05 82.09 88.02 63.64 40.89
Manufacturing expenses 19.44 20.98 18.88 12.95 10.40
Personnel expenses 21.92 21.03 19.03 15.87 14.50
Selling expenses 0.81 0.35 0.47 - 0.14
Adminstrative expenses 9.46 10.24 14.95 7.17 7.71
Expenses capitalised - - - - -
Cost of sales 134.67 134.68 141.35 99.63 73.65
Operating profit 15.95 11.18 11.11 15.72 11.49
Other recurring income 4.76 2.74 3.52 3.27 2.10
Adjusted PBDIT 20.70 13.92 14.63 18.99 13.59
Financial expenses 3.66 2.73 2.29 2.04 0.79
Depreciation 6.07 4.89 5.00 5.33 5.49
Other write offs - - - - -
Adjusted PBT 10.97 6.30 7.35 11.62 7.31
Tax charges -0.13 - - 0.28 -
Adjusted PAT 11.10 - - 11.34 -
Non recurring items - -2.33 0.04 0.15 -2.16
Other non cash adjustments - - - - -
Reported net profit 11.10 3.97 7.38 11.49 5.15
Earnigs before appropriation -32.01 -43.13 -47.10 -54.48 -66.01
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings -32.01 -43.13 -47.10 -54.48 -66.01
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback